Rep. David Cicilline David Nicola CicillineClark rolls out endorsements in assistant Speaker race Races heat up for House leadership posts The folly of Cicilline's 'Glass-Steagall for Tech' MORE (D-R.I.) called Tuesday on the director of the Centers for Disease Control and Prevention (CDC) to alert state governments to incoming travelers arriving from countries experiencing coronavirus outbreaks.

In a letter obtained by CBS affiliate WPRI, Cicilline pointed to recent reports of the virus in Rhode Island resulting in dozens of state residents being monitored for the disease as an example of why agencies should be alerted as early as possible to potential carriers.

"I strongly urge the CDC to provide notifications to state agencies when travelers arrive in the U.S. from other countries with significant or elevated reports of incidents of COVID-19," he wrote, using the official term for the virus.

ADVERTISEMENT

"Transparency during this time is critical to ensuring that Americans have access to accurate and timely information needed to prevent contamination and to seek treatment when appropriate," Cicilline added.

JUST IN: @DavidCicilline has sent a sharply worded letter to the CDC chief strongly urging him to alert states to travelers returning from *any* countries with COVID-19 outbreaks - not just China



RI got no heads up about the Italy travelers who brought the virus here, he notes pic.twitter.com/INeip5dLFI — Ted Nesi (@TedNesi) March 3, 2020

Democrats have hammered the Trump administration over its response to the global coronavirus outbreak thus far, accusing the president of downplaying the virus's seriousness while President Trump Donald John TrumpBarr criticizes DOJ in speech declaring all agency power 'is invested in the attorney general' Military leaders asked about using heat ray on protesters outside White House: report Powell warns failure to reach COVID-19 deal could 'scar and damage' economy MORE himself has accused Democrats of perpetrating a "hoax" over the issue.

The CDC itself also has come under scrutiny amid the outbreak after it was revealed that it failed its first attempt to mass-produce a test kit for the disease.